An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

NCT01592786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

906

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder (ASD)
Autism
Autistic Disorder
Asperger's Disorder
Asperger's
Pediatric Autism
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Interventions

DRUG: Memantine Hydrochloride (HCl)

Sponsor

Forest Laboratories